Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022

SELL
$2.5 - $4.25 $35,255 - $59,933
-14,102 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$3.86 - $6.65 $54,433 - $93,778
14,102 New
14,102 $57,000
Q3 2021

Nov 15, 2021

SELL
$5.98 - $8.0 $101,845 - $136,248
-17,031 Closed
0 $0
Q2 2021

Aug 16, 2021

SELL
$5.9 - $9.46 $88,134 - $141,313
-14,938 Reduced 46.73%
17,031 $132,000
Q1 2021

May 17, 2021

BUY
$4.47 - $12.99 $35,514 - $103,205
7,945 Added 33.07%
31,969 $269,000
Q4 2020

Feb 16, 2021

BUY
$3.5 - $5.44 $84,084 - $130,690
24,024 New
24,024 $117,000

Others Institutions Holding JAN

About JanOne Inc.


  • Ticker JAN
  • Exchange NASDAQ
  • Sector Industrials
  • Industry Waste Management
  • Shares Outstandng 3,150,230
  • Market Cap $6.49M
  • Description
  • JanOne Inc., a clinical-stage biopharmaceutical company, focuses on identifying, acquiring, licensing, developing, partnering, and commercializing novel, non-opioid, and non-addictive therapies to address the unmet medical need for the treatment of pain and addiction. It operates through three segments: Biotechnology, Recycling, and Technology. ...
More about JAN
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.